Fumaric Acid

Fumaric Acid

SCHEMBL1936089

CCCN(C(=O)CC1CCN(C)CC1)c1ccc(Cl)c(Cl)c1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SLC6A2 known ✓ P23975 1/20 0.36
SLC6A4 known ✓ P31645 1/20 0.36
DRD2 known ✓ P14416 1/20 0.36
CCR5 P51681 10/20 0.39
PGR P06401 1/20 0.39
ACHE P22303 1/20 0.38
TP53 P04637 2/20 0.37
OPRM1 P35372 3/20 0.36
SLC6A3 Q01959 1/20 0.36
DRD1 P21728 1/20 0.36
DRD5 P21918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2393607 0.94 PGR (0.43) CCR5PGRACHETP53OPRM1
Fumaric Acid SCHEMBL1936521 0.90 ACHE (0.41) CCR5PGRACHETP53OPRM1
Fumaric Acid SCHEMBL1935056 0.87 SLC6A4 (0.42) TP53SLC6A2SLC6A4SLC6A3
Fumaric Acid SCHEMBL1934781 0.85 CCR2 (0.39) SLC6A2SLC6A4SLC6A3DRD2DRD1
Fumaric Acid SCHEMBL1936098 0.85 CCR5 (0.42) CCR5OPRM1
SCHEMBL2395603 0.85 CCR5 (0.41) CCR5PGROPRM1SLC6A2SLC6A4
Hydrochloric Acid SCHEMBL2396854 0.84 OPRM1 (0.41) CCR5PGROPRM1SLC6A2SLC6A4
SCHEMBL3364749 0.83 ACHE (0.43) CCR5PGRACHETP53OPRM1
Fumaric Acid SCHEMBL1936311 0.83 DRD2 (0.35) PGRACHETP53OPRM1SLC6A2
Fumaric Acid SCHEMBL2394308 0.83 PGR (0.35) CCR5PGRACHETP53OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212997-A1 PIPERIDINE-4-ACETAMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NEUROSEARCH A/S (DK) 2011-09-01 US disclosed
EP-2331505-A2 PIPERIDINE-4-ACETAMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NeuroSearch A/S (DK) 2011-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212997-A1 PIPERIDINE-4-ACETAMIDE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS SLC18A2, SLC6A2, SLC18A3 SLC6A2 2/4885SLC6A4 4/4885DRD2 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.